BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 290.00K | 334.00K | 505.00K | 437.00K | 554.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 290.00K | 334.00K | 505.00K | 437.00K | 554.00K |
| Cost of Revenue | 82.00K | 103.00K | 172.00K | 149.00K | 192.00K |
| Gross Profit | 208.00K | 231.00K | 333.00K | 288.00K | 362.00K |
| SG&A Expenses | 649.00K | 924.00K | 1.28M | 1.06M | 1.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.13M | 1.36M | 1.95M | 1.69M | 1.77M |
| Operating Income | -843.00K | -1.03M | -1.45M | -1.26M | -1.21M |
| Income Before Tax | -902.00K | -1.02M | -2.03M | -1.35M | -1.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -902.00K | -1.02M | -2.03M | -1.35M | -1.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -902.00K | -1.02M | -2.03M | -1.35M | -1.32M |
| EBIT | -843.00K | -1.03M | -1.45M | -1.26M | -1.21M |
| EBITDA | -825.00K | -1.01M | -1.42M | -1.23M | -1.18M |
| EPS Basic | -0.08 | -0.27 | -0.23 | -0.16 | -0.15 |
| Normalized Basic EPS | -0.05 | -0.06 | -0.15 | -0.10 | -0.10 |
| EPS Diluted | -0.08 | -0.27 | -0.23 | -0.16 | -0.15 |
| Normalized Diluted EPS | -0.05 | -0.06 | -0.15 | -0.10 | -0.10 |
| Average Basic Shares Outstanding | 11.26M | 9.86M | 8.66M | 8.64M | 8.61M |
| Average Diluted Shares Outstanding | 11.26M | 9.86M | 8.66M | 8.64M | 8.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
